It's an ironic twist as the coronavirus pandemic sweeps the nation: The very workers tasked with treating those afflicted with the virus are losing work in droves.
More than half of U.S. states have started lifting pandemic restrictions and reopening their economies. But questions remain about how to resume business while maintaining social distancing. In addition, testing for COVID-19 remains relatively limited, with about 250,000 tests per day conducted nationwide.
A new study finds no evidence of benefit from a malaria drug widely promoted as a treatment for coronavirus infection. Hydroxychloroquine did not lower the risk of dying or needing a breathing tube in a comparison that involved nearly 1,400 patients treated at Columbia University in New York, researchers reported Thursday in the New England Journal of Medicine.
Treating coronavirus patients with blood thinners could help boost their prospects for survival, according to preliminary findings from physicians at New York City’s largest hospital system that offer another clue about treating the deadly condition.
By the time my son-in-law drove himself to the hospital, the virulent infection coursing through his abdomen had invaded his appendix. And what might have been routine surgery and a one-night hospital stay would turn into two torturous weeks of fear, pain and paranoia, in a setting transformed by the coronavirus crisis.